Colorectal Neoplasms Clinical Trials in Portland, Oregon

5 studies are recruiting for colorectal neoplasms in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

   The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, oxaliplatin (mFOLFOX6) or 5-fluorouracil, leucovorin calcium (folin…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Oregon Health And Science University, Portland, Oregon

   Locations

   239 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT06662786 on ClinicalTrials.gov

2. A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

   The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall survival), when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovo…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Oregon Health And Science University, Portland, Oregon

   Locations

   251 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT06750094 on ClinicalTrials.gov

3. Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

   The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon or rectum (CRC)). The goal is to understand if the new study medicine, combined with chemotherapy that is approved for colorectal cancer, can help people whos…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Kaiser Permanente Interstate Medical Office Central, Portland, Oregon

   Locations

   308 in total

   Run by

   Pfizer

   See if you can join NCT07222800 on ClinicalTrials.gov

4. Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

   This is a multi-site comparative effectiveness randomized controlled trial (RCT) comparing annual fecal immunochemical testing (FIT) and colonoscopy for post-polypectomy surveillance among adults aged 65-82 with a history of colorectal polyps who are due for surveillance colonoscopy.

   Stage

   Not phased

   Ages

   65 to 82

   Site

   Oregon Health & Science University (Knight Cancer Institute), Portland, Oregon

   Locations

   24 in total

   Run by

   Dartmouth-Hitchcock Medical Center

   See if you can join NCT05612347 on ClinicalTrials.gov

5. A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

   This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anythin…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Providence Cancer Institute Franz Clinic, Portland, Oregon

   Locations

   366 in total

   Run by

   Seagen, a wholly owned subsidiary of Pfizer

   See if you can join NCT05253651 on ClinicalTrials.gov